期刊文献+

螺旋CT动态增强扫描对肝细胞癌合并门静脉癌栓的诊断价值(附32例分析)

Diagnostic value of helical CT dynamic contrast enhancement scan for hepatocellular carcinoma associated with portal tumor thrombus(An analysis of 32 eases)
下载PDF
导出
摘要 目的探讨肝细胞癌合并门静脉癌栓发生机制和螺旋CT动态增强扫描的表现。方法32例肝细胞癌门静脉癌栓形成的患者作螺旋CT平扫和增强扫描,10例进行了多平面重组(MPR)成像,9例患者治疗后作CT随访。结果螺旋CT轴位和MPR图像能清晰显示门静脉癌栓,直接的CT征象为门静脉增粗及充盈缺损,门脉血管软组织肿块影和门静脉癌栓内及周围可见网状供血动脉。间接征象主要有侧支循环形成及周围肝脏动力学的改变。螺旋CT扫描可以评价门静脉癌栓治疗后的变化情况。结论螺旋CT动态增强扫描轴位图像结合MPR可以完整地提供门静脉癌栓的影像资料,对肝细胞癌患者治疗方法的选择及预后判断具有重要价值。 Objective To study the pathogenic mechanism of hepatocellular carcinomaassociated with portal tumro thrombus and the manifestation of helical CT dymamic contrastenhancement scan.Methods From January 2004 to October 2005,169 cases with hepatocellularcarcinoma received examination of helical CT dynamic contrast enhancement scan.Among them,32cases with portal fumor thrombus were found and one was anulyzed eom-prehensively.Results Theimaging manifestation of 32 cases with hepatocellular carcinoma associated with portal tumorthrombuswere enlarged portal vein and dilatation,intraluminal filling defect of portal vein and cylindric ordendritic tumor thrombus.Conelusion Helical CT cancorrectly judge the position of hepatoeellularcarcinoma associated with portal tumor thrombus,extent of tumor thrombus and it's relationshipbetween the peripheral tissues or structures,If has an important significance for the treatment ofhepatocellular carcinoma.
出处 《岭南现代临床外科》 2006年第2期115-116,122,共3页 Lingnan Modern Clinics in Surgery
关键词 肝细胞癌 门静脉 体层摄影术 X线计算机 三维重建 Hepatocellular carcinoma Portal vein Embolus Tomography Xray computer
  • 相关文献

参考文献6

二级参考文献24

  • 1张龙江,马宁,宋光义,祁吉.原发性肝细胞癌的多层CT血管造影表现及临床应用价值[J].中国医学影像技术,2004,20(7):1084-1087. 被引量:9
  • 2谢琦,郑国梁,林浩皋,李国辉.原发性肝细胞癌病灶形态学的CT研究[J].中华肿瘤杂志,1994,16(1):32-35. 被引量:7
  • 3贾雨辰,刘崎,贺佳,王振堂,陈栋,孙飞,田建明.肝癌介入治疗中预后因素的分析[J].肝胆外科杂志,1995,3(3):143-146. 被引量:4
  • 4[1]Lu DS, Saini S, Hahn PF, et al. T2 weighted MR imaging of the upper part of the abdomen: should fat suppression be used routinly [J]. AJR, 1994, 162 (5): 1095- 1100.
  • 5[2]Reimer P, Muller M, Marx C, et al. T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555A: dependence on field strength preliminary dynamic T1 weighted MR imaging [J]. Radiology, 1998, 209 (3): 831- 836.
  • 6[3]Mergo PJ, Engelken JD, Helmberger T, et al. MRI in focal liver disease: a comparison of small and ultrasmall supermagnetic iron oxide as hepatic contrast agents [J]. JMRI, 1998, 8(5): 1073- 1078.
  • 7[4]Tanaka M, Nakashima O, Wada Y, et al. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver [J]. Hepatology, 1996, 24(4): 807- 812.
  • 8[5]Yamamoto H, Yamashita Y, Yoshimatsu S, et al. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging [J]. Radiology, 1995, 195(1): 106- 112.
  • 9[6]Adachi E, Maeda T, Kajiyama K, et al. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments [J]. Cancer, 1996, 77(10): 2022- 2031.
  • 10吴东,临床放射学杂志,1999年,18卷,272页

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部